Vande Mataram now mandatory in all schools, universities, offices in TN

Bengaluru, May 31: In spite of opposition, chief minister BS Yediyurappa has appointed his former personal assistant and maternal grandnephew NR Santosh as his political secretary.

Santosh is the fourth political secretary to the CM besides SR Vishwanath, MP Renukacharya and Shankaranna Munavalli. 

Santosh was arrested for allegedly trying to kidnap Vinay NS, personal assistant of BJP leader KS Eshwarappa in 2017. He's also facing attempt to murder and dowry harassment charges.

The 30-year-old had fallen out with the CM's younger son BY Vijayendra soon after the BJP came to power and had been reportedly asked to keep away from him. He had identified with some MLAs who were up against the CM.

It's said the appointment was made to send out a message to the rivals after some MLAs launched a renewed campaign against Yediyurappa over a dinner meeting at BJP MLA Umesh V Katti's house. 

Though Yediyurappa was not keen, sources said Santosh brought pressure from RSS and some BJP leaders, whose help he had sought to reunite with the family. 

Santosh from Tumakuru is the son of the CM's sister's daughter. He was Yediyurappa's Man Friday and his job was confined to ensuring he took his medicines on time.

Bengaluru, Jun 24:  Karnataka on Wednesday reported 397 new coronavirus positive cases, taking the total number of positive cases to 10,118.

According to the State Health Department, with 14 more deaths today, the state's toll has reached 164. While, 6,151 people have been discharged so far.

Hundred per cent of Community Health Centres, 50 per cent of Primary Health Centres and Urban Primary Health Centres will be converted as exclusive 'fever clinics' to screen fever cases for influenza-like illness (ILI)/severe acute respiratory infections (SARI), Karnataka Health Department said.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.